215 related articles for article (PubMed ID: 20933017)
1. Adaptation of a Madin-Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines.
van Wielink R; Kant-Eenbergen HC; Harmsen MM; Martens DE; Wijffels RH; Coco-Martin JM
J Virol Methods; 2011 Jan; 171(1):53-60. PubMed ID: 20933017
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of influenza virus replication in Vero and MDCK cell lines.
Youil R; Su Q; Toner TJ; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Kiseleva I; Shaw AR; DiStefano D
J Virol Methods; 2004 Sep; 120(1):23-31. PubMed ID: 15234806
[TBL] [Abstract][Full Text] [Related]
3. Use of MDCK cells for production of live attenuated influenza vaccine.
Liu J; Shi X; Schwartz R; Kemble G
Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113
[TBL] [Abstract][Full Text] [Related]
4. Production of influenza virus in serum-free mammalian cell cultures.
Merten OW; Manuguerra JC; Hannoun C; van der Werf S
Dev Biol Stand; 1999; 98():23-37; discussion 73-4. PubMed ID: 10494957
[TBL] [Abstract][Full Text] [Related]
5. [Adherent and single-cell suspension culture of Madin-Darby canine kidney cells in serum-free medium].
Huang D; Zhao L; Tan W
Sheng Wu Gong Cheng Xue Bao; 2011 Apr; 27(4):645-52. PubMed ID: 21848001
[TBL] [Abstract][Full Text] [Related]
6. High titer growth of human and avian influenza viruses in an immortalized chick embryo cell line without the need for exogenous proteases.
Smith KA; Colvin CJ; Weber PS; Spatz SJ; Coussens PM
Vaccine; 2008 Jul; 26(29-30):3778-82. PubMed ID: 18524432
[TBL] [Abstract][Full Text] [Related]
7. The growth of attenuated influenza vaccine donor strains in continuous cell lines.
Audsley JM; Tannock GA
J Virol Methods; 2005 Feb; 123(2):187-93. PubMed ID: 15620401
[TBL] [Abstract][Full Text] [Related]
8. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process.
George M; Farooq M; Dang T; Cortes B; Liu J; Maranga L
Biotechnol Bioeng; 2010 Aug; 106(6):906-17. PubMed ID: 20589670
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of chicken-origin (DF-1) and quail-origin (QT-6) fibroblast cell lines for replication of avian influenza viruses.
Lee CW; Jung K; Jadhao SJ; Suarez DL
J Virol Methods; 2008 Oct; 153(1):22-8. PubMed ID: 18638503
[TBL] [Abstract][Full Text] [Related]
10. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.
Genzel Y; Fischer M; Reichl U
Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544
[TBL] [Abstract][Full Text] [Related]
11. High yields of influenza A virus in Madin-Darby canine kidney cells are promoted by an insufficient interferon-induced antiviral state.
Seitz C; Frensing T; Höper D; Kochs G; Reichl U
J Gen Virol; 2010 Jul; 91(Pt 7):1754-63. PubMed ID: 20357039
[TBL] [Abstract][Full Text] [Related]
12. Suitability of MDCK cells grown in a serum-free medium for influenza virus production.
Kessler N; Thomas-Roche G; Gérentes L; Aymard M
Dev Biol Stand; 1999; 98():13-21; discussion 73-4. PubMed ID: 10494956
[TBL] [Abstract][Full Text] [Related]
13. Generation and characterization of reassortant influenza A viruses propagated in serum-free cultured MDCK-SF1 cells.
Voeten JT; Claas EC; Brands R; Palache AM; van Scharrenburg GJ; Rimmelzwaan GF; Osterhaus AD
Dev Biol Stand; 1999; 98():77-87; discussion 89-90. PubMed ID: 10494961
[TBL] [Abstract][Full Text] [Related]
14. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
Govorkova EA; Kodihalli S; Alymova IV; Fanget B; Webster RG
Dev Biol Stand; 1999; 98():39-51; discussion 73-4. PubMed ID: 10494958
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of different cell lines to Avian and Swine Influenza viruses.
Lombardo T; Dotti S; Renzi S; Ferrari M
J Virol Methods; 2012 Oct; 185(1):82-8. PubMed ID: 22728276
[TBL] [Abstract][Full Text] [Related]
16. Mathematical model of influenza A virus production in large-scale microcarrier culture.
Möhler L; Flockerzi D; Sann H; Reichl U
Biotechnol Bioeng; 2005 Apr; 90(1):46-58. PubMed ID: 15736163
[TBL] [Abstract][Full Text] [Related]
17. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.
Genzel Y; Olmer RM; Schäfer B; Reichl U
Vaccine; 2006 Aug; 24(35-36):6074-87. PubMed ID: 16781022
[TBL] [Abstract][Full Text] [Related]
18. Immortalized chick embryo cell line adapted to serum-free growth conditions and capable of replicating human and reassortant H5N1 influenza strains for vaccine production.
Coussens PM; Smith KA; Weber PS; Colvin CJ
Vaccine; 2011 Nov; 29(47):8661-8. PubMed ID: 21911025
[TBL] [Abstract][Full Text] [Related]
19. Comparison of influenza virus yields and apoptosis-induction in an adherent and a suspension MDCK cell line.
Peschel B; Frentzel S; Laske T; Genzel Y; Reichl U
Vaccine; 2013 Nov; 31(48):5693-9. PubMed ID: 24113260
[TBL] [Abstract][Full Text] [Related]
20. New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation.
Lohr V; Rath A; Genzel Y; Jordan I; Sandig V; Reichl U
Vaccine; 2009 Aug; 27(36):4975-82. PubMed ID: 19531390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
